Abstract

Breast cancers differ in response to treatment and may have a divergent clinical course despite having a similar histopathological appearance. New technology using DNA microarrays provides a systematic method to identify key markers for prognosis and treatment response by profiling thousands of genes expressed in a single cancer. Microarray profiling of 38 invasive breast cancers now confirms striking molecular differences between ductal carcinoma specimens and suggests a new classification for oestrogen-receptor negative breast cancer. Future approaches will need to include methods for high-throughput clinical validation and the ability to analyze microscopic samples.

Keywords

Breast cancerSurgical oncologyDNA microarrayMicroarrayMedicineGene expression profilingOncologyInternal medicineDuctal carcinomaBioinformaticsPathologyCancerBiologyGeneGene expressionGenetics

Affiliated Institutions

Related Publications

Publication Info

Year
2001
Type
review
Volume
3
Issue
2
Pages
77-77
Citations
34
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

34
OpenAlex

Cite This

James D. Brenton, Samuel Aparício, Carlos Caldas (2001). Molecular profiling of breast cancer: portraits but not physiognomy.. Breast Cancer Research , 3 (2) , 77-77. https://doi.org/10.1186/bcr274

Identifiers

DOI
10.1186/bcr274